New Research Service Standard Operating Procedures Kimberly Summers, PharmD Assistant Chief for Clinical Research South Texas Veterans Health Care System.

Slides:



Advertisements
Similar presentations
The Role of the IRB An Institutional Review Board (IRB) is a review committee established to help protect the rights and welfare of human research subjects.
Advertisements

Managing Compliance Related to Human Subjects Research Review Joseph Sherwin, Ph.D. Office of Regulatory Affairs University of Pennsylvania Fourth Annual.
Tips to a Successful Monitoring Visit
Open Library June 4, 2004 Informed Consent Process and Federal Regulations That Must Be Met to Waive Informed Consent Tracey Craddock Regulatory Compliance.
RESEARCH COMPLIANCE Agenda 1. No Destruction of local research documents after scanning 2. Training for shipping biological samples/specimens 3. Regulatory.
UTHSC IRB Donna Hollaway, RN, CCRC 11/30/2011 Authority to Audit 45 CFR (e) An IRB shall conduct continuing review of research covered by this.
Health Insurance Portability Accountability Act of 1996 HIPAA for Researchers: IRB Related Issues HSC USC IRB.
Office of Research Oversight. Working Group Report Slide 2.
IRB Determinations 1. AAHRPP Site Visit Results Site visitors observed a real commitment to human subject protections Investigator and research staff.
Recently Issued OHRP Documents: Guidance on Subject Withdrawal and Draft Revised FWA Secretary’s Advisory Committee on Human Research Protections October.
Pharmacists Responsibilities in Clinical Studies Mike R Sather, PhD Crystal L Harris, PharmD February 26, 2004.
CUMC IRB Investigator Meeting Human Subjects Research Non-Compliance September 15, 2005.
Human Research Protection Program Training: Post-Approval Event Reporting March 26, 2008 Lisa Voss, MPH, CIP Assistant Director, QIU Human Research Protection.
Office of Research Oversight VHA Handbook Research Conducted by VHA Program Office Employees Effective May 1, 2012 October 28, 2011.
Documentation of Human Subjects Research in the Patient’s Health Record Kimberly Summers, PharmD Assistant Chief for Clinical Research South Texas Veterans.
Unlocking the Mystery of General Information Reporting Research Compliance Administration Training Presentation Wednesday, June 6, 2007 Presenter:Heather.
VA Research: IRB and R&D Approval Process From Initial Submission, Through the Informed Consent Process and Continuing Review, To Inactivation Kimberly.
Institutional Review Board (IRB) Human Subject Research Office (HSRO) University of Miami and Affiliated Institutions.
2012 VA IRB Administrators Meeting Stephania H. Griffin, JD, RHIA, CIPP/G VHA Privacy Officer Director, Information Access and Privacy Privacy Officer.
International Research & Research Involving Children K. Lynn Cates, MD Assistant Chief Research & Development Officer Office of Research & Development.
Research and Development Protocol Submission and Continuing Review Processes Kimberly Summers, PharmD Assistant Chief for Clinical Research South Texas.
Carolyn Hommel Good Clinical Practice Program FDA February 25, 2004
Elements of Clinical Trial Quality Assurance Regulatory Coordinator –SCTR SUCCESS Center QA Monitor – NIDA Clinical Trials Network Stephanie Gentilin,
ORO Reviews: Frequent Findings Related to IRBs Bob Brooks Associate Director Research Compliance Education and Policy VHA Office of Research Oversight.
Sara Brand Associate Director Research Compliance Administration.
Common Audit Findings UTHSC Institutional Review Board (IRB)
RESCUE: ACRIN 4701 Protocol Development & Regulatory Compliance (PDRC) Josephine Schloesser, ACRIN Monitor Chris Steward, ACRIN QC Auditor.
Preparing For A VA Compliance Audit Kimberly Summers, PharmD Assistant Chief for Clinical Research South Texas Veterans Health Care System, San Antonio,
Joint Research & Enterprise Office Training The team, the procedures, the monitor and the Sponsor Lucy H H Parker Clinical Research Governance Manager.
Michelle Groy Johnson Quality Improvement Officer Research Integrity Office Tough Love: Understanding the Purpose and Processes of Quality Assurance.
STVHCS Research and Development Kimberly Summers, PharmD Assistant Chief for Clinical Research South Texas Veterans Health Care System Research & Development.
University of Miami Office of Research Compliance Assessment Lynn E. Smith, JD, CIM, CIP Johanna Stamates, RN, BA, CCRC With assistance from Elizabeth.
Research Auditing Presented by: Darlene Krueger, MBA RN CCRA Chief, GCP Auditing & Training VA Cooperative Studies Program Albuquerque, NM.
Monitoring IRB Monitoring of Clinical Trials. Types of Monitoring Internally Internally Externally Externally.
Ensuring Human Subject Protection A Guide for Those who Obtain Research Informed Consent Documents 10/15/20151.
Questions: AAHRPP Evaluation Instrument for Use with Final Revised Accreditation Standards Presented by: C. Karen Jeans, MSN, CCRN, CIP COACH Program Analyst,
H I P A A T R A I N I N G Self Directed Module 7 Research Disclosures For Data Custodians START Click to begin…
VA Central IRB Annette R. Anderson, MS, RHIA, CIP VA Central IRB Administrator HRPP 101, September 2010.
Building Clinical Infrastructure and Expert Support Michael Steinberg, MD, FACR ULAAC Disparity Project Centinela/Freeman Health System.
VHA Handbook “Research Compliance Reporting Requirements” Version: June 15, 2015 ORO Presentation: July 14 and 16, 2015.
UC DAVIS OFFICE OF RESEARCH Overview of Good Clinical Practices (GCP) Investigator and Study Team Responsibilities Miles McFann IRB Administration Training.
Conducting Clinical Risk Assessments And Implementing Compliance Practices Jane L. Stratton Chiron Corporation VP/Associate General Counsel Chief Compliance.
Office of Research & Development (ORD) Local Accountability of Research 2009 Baltimore, Maryland January 13-14, 2009 “Meeting the Current Challenges of.
Human Research Protection Program & IRB Responsibilities Marisue Cody, PhD Director Center on Advice & Compliance Help.
AUDIT REQUIREMENTS, FINDINGS & BASICS RESEARCH COMPLIANCE.
VHA Handbook What’s new. General Requirements for Informed Consent A Legally Authorized Representative may not always qualify as a ‘personal representative’
OBSERVED IN ORO REVIEWS COMPLIANCE ISSUES: OBSERVED IN ORO REVIEWS David A. Weber, Ph.D., FACNP Acting Chief Officer Office of Research.
VA Central IRB Annette R. Anderson, MS, RHIA, CIP VA Central IRB Administrator Local Accountability Meeting June 2011.
Investigational Devices and Humanitarian Use Devices June 2007.
The NCI Central IRB Initiative Jacquelyn L. Goldberg, J.D. VA IRB Chair Training April 8, 2004.
HRPP Policies & Forms Chapter Two Created/Revised for AAHRPP June 1, 2007.
Office of Research Oversight 1 Office of Research and Development Local Accountability Meeting January 2009.
Paul Kelly Facility Research Compliance Officer for the Ralph H. Johnson VA Medical Center.
RIHES-II: H ANDLING A UDITS AND I NSPECTIONS E FFECTIVE D ATE 25 D ECEMBER 2006 V ERSION : 3.0 บุญเหลือ พรึงลำภู 15 มกราคม 2557.
Office of Human Research Protection Georgia Health Sciences University.
The TJU Human Research Protection Program (HRPP): Part I – Which Entities/Offices are Involved ? J. Bruce Smith, MD, CIP.
Office of Research & Development (ORD) Local Accountability of Research 2009 Baltimore, Maryland January 13-14, 2009 “Meeting the Current Challenges of.
VA Central IRB K. Lynn Cates, MD Assistant Chief Research & Development Officer Office of Research & Development Department of Veterans Affairs.
VA Central IRB K. Lynn Cates, MD Assistant Chief Research & Development Officer Office of Research & Development Department of Veterans Affairs September.
Marianne M. Elliott Office of Research Integrity and Ethics Bureau of Medicine and Surgery U. S Navy.
Informed Consent Presented by Marian Serge, RN. Goals Informed consent process and form Title 38 CFR , Common Rule required elements and additional.
HIPAA and RESEARCH 5 th Thursday May 31, Page 2.
Responsibilities of Sponsor, Investigator and Monitor
Cancer Clinical Trials Office Clinical Trials & Research Training Oct2014.
HIPAA 2017 JHSPH IRB Clarifications and Changes
Office of Animal Welfare Assurance (OAWA) Janna Barcelo, BA, CPIA
Responsibilities of Sponsor, Investigator and Monitor
The HIPAA Privacy Rule: Implications for Medical Research
IRB reporting updates.
Reportable Events & Other IRB Updates February 2017
Presentation transcript:

New Research Service Standard Operating Procedures Kimberly Summers, PharmD Assistant Chief for Clinical Research South Texas Veterans Health Care System Research & Development Service

Standard Operating Procedures External Clinical Research Monitoring VisitsExternal Clinical Research Monitoring Visits Subject Recruitment and AdvertisingSubject Recruitment and Advertising Clinical Impact StatementsClinical Impact Statements

Monitoring By External Agencies Entities external to the facilityEntities external to the facility –Pharmaceutical companies –Study sponsors –Contract Research Organizations (CROs) –VA Cooperative Studies Program Monitors Site visitsSite visits –Routine –Conducted for specific cause

External Clinical Research Monitoring Visits VHA Memorandum From Chief Research and Development OfficerVHA Memorandum From Chief Research and Development Officer –Thru Deputy Under Secretary for Health –Subject: Reporting of All Study Site- Monitoring Visit Results –Charge: Each research office must develop procedures that will ensure all serious findings and concerns are appropriately addressed and the appropriate facility officials and committees are notified

Research Office Notification Findings and issues of concern must be forwarded to appropriate facility officials and committeesFindings and issues of concern must be forwarded to appropriate facility officials and committees –This is the responsibility of the Research office –Component of the STVHCS Human Subjects Protection Program (HRPP) If no serious findings or concerns are identified, the Research office must be notified in writing that there were no such findingsIf no serious findings or concerns are identified, the Research office must be notified in writing that there were no such findings

Why is Compliance with this Memorandum Important?

Office of Research Oversight (ORO) Primary VHA office in advising the Under Secretary for Health on all matters of compliance and assurance including:Primary VHA office in advising the Under Secretary for Health on all matters of compliance and assurance including: –Human subject protections –Animal welfare –Research safety and security –Research data security –Research misconduct Oversight is enforced by:Oversight is enforced by: –Performing periodic prospective and for-cause reviews –Conducting investigations –Assuring compliance with the laws, regulations, and policies applicable to VHA research.

Local Example Research office unaware of serious issues identified by external study monitors for a VA- approved research protocol Corrective actions were not put into place Serious consequences for the institution and investigator resulted

Upon Notice of Monitoring Visit Research staff scheduling or confirming the monitoring visit must notify the Research officeResearch staff scheduling or confirming the monitoring visit must notify the Research office –For scheduled monitoring visits notification should be by to –For unscheduled monitoring visits notification may be by phone (210) directed to Kimberly Summers, Assistant Chief for Clinical Research Notification should be made as soon as study personnel are aware of the visitNotification should be made as soon as study personnel are aware of the visit

At The Time Of The Monitoring Visit Study monitor must sign in at the Research Office and receive a visitor badgeStudy monitor must sign in at the Research Office and receive a visitor badge –Check-in at Room Q202.1 –A Research Monitor Log will be maintained by the Research Office Study monitor will be providedStudy monitor will be provided –External Monitor Agreement Form Must be reviewed and signed at the time of check inMust be reviewed and signed at the time of check in –STVHCS Report of Clinical Research Monitoring Visit Must be returned to the Research officeMust be returned to the Research office

External Research Monitor Log

Visitor Badges Badges will be issued in exchange for a picture ID Badge must be worn at all times Badges must be returned to the Research office by 4:30pm – –If monitors will be conducting business past 4:30pm they should return to the Research office prior to 4:30 for their state issued ID and the responsible investigator or study staff must ensure the badge is returned the next business day Lost or stolen badges will be assessed a $25 fee to the responsible investigator Monitors assigned the visitor badge must be accompanied by a VA employee (paid or WOC)

Completion is required independent of the findings associated with the visit

Findings That Require an Exit Interview Suspicions or concerns that serious non- compliance may existSuspicions or concerns that serious non- compliance may exist All findings of serious non-compliance with study protocol, IRB requirements or applicable regulations and policiesAll findings of serious non-compliance with study protocol, IRB requirements or applicable regulations and policies Monitoring visits conducted by regulatory agencies (FDA, OHRP)Monitoring visits conducted by regulatory agencies (FDA, OHRP)

Compliance With External Clinical Research Monitoring Policies and SOPs STVHCS Compliance OfficeSTVHCS Compliance Office –Will verify results of external clinical research monitoring visits were reported to the R&D Office –Component of routine monitoring of investigator records Office of Research Oversight (ORO)Office of Research Oversight (ORO) –May perform periodic prospective and for-cause reviews to assure compliance with the laws, regulations, and policies applicable to VHA research STVHCS PoliceSTVHCS Police –Will audit appropriate security measures are in place for all visitors related to research –Will audit check-in and assignment of badges

Human Subjects Clinical Research Recruitment and Advertising

Recruitment “Researcher Contact with Veterans” – –VHA Memorandum 7/10/06 IRB-approved mechanisms – –Physician referral – –Posting of IRB-approved advertisements “Preparatory to Research” by HIPAA Privacy Rule – –VA guidelines are more restrictive

Researcher Contacts with Veterans All non-essential contact of veterans must stop – –Clinically essential contact that cannot be deferred is allowed – –Contact shall not solicit sensitive information Contact by researchers and study staff must be limited to procedures and data elements outlined in IRB and R&D approved protocols During recruitment – –Initial contact must be in person and/or by letter – –A telephone number must be provided for the veteran to verify the validity of the study – – website may be providedhttp:// Following recruitment and during follow-up – –All telephone calls should begin by referring to previous contacts and information provided in the informed consent document 7/10/06 Principal Deputy Under Secretary for Health Memorandum

Physician Referral Veteran patients may be formally referred from VA staff for a VA-approved research protocol Veteran patients may NOT be formally referred from VA staff to off-site locations for non-VA approved research protocols – –Veteran patients have a right to seek care from and enroll in research studies outside the VA – –Informing veteran patients of the availability of an outside research study is not considered a referral, if the referring physician will not have ongoing participation in the care of the patient

Informing Veterans About Off-site Non-VA Research Studies Veterans must be informed that VA will not be responsible for any costs related to their care as part of the off-site research Enrollment should occur through the veterans’ own initiative in contacting the study personnel at the off-site institution Provision of information to a veteran regarding off-site research and their associated responsibility for cost should be documented by the VA physician in a progress note in CPRS VA records may not be accessed to obtain information for research purposes of a non-VA off-site study

Recruitment Advertisements Posted at the STVHCS Steps requiredSteps required –Approved and stamped by UTHSCSA IRB –Verification of active protocol and stamped by VA Research Office –Posting approval by VA Public Affairs Office Recruitment of VA patients into non-VA studies through posted advertisements in NOT allowedRecruitment of VA patients into non-VA studies through posted advertisements in NOT allowed

Expedited Posting Following IRB approval Investigator or study staff may hand deliver advertisementFollowing IRB approval Investigator or study staff may hand deliver advertisement –R&D office RM Q202RM Q202 Will verify study approval and stampWill verify study approval and stamp –Public Affairs office RM 118RM 118 Will approve and stamp for postingWill approve and stamp for posting –May be posted same day

“Preparatory to Research” Review of individually-identifiable information by a VA investigator to prepare a research protocol does not require IRB or R&D approval Examples: to generate a hypothesis, determine feasibility to conduct a study, determine the number of eligible patients In the VA, using individually-identifiable information to contact potential research subjects as part of recruitment into a research protocol is NOT considered “preparatory to research” – –VA regulations differ from those described in the HIPAA Privacy Rule – –IRB and R&D Committee review and approval required – –IRB approved waiver of authorization and waiver of informed consent required Pilot studies are NOT considered part of the activities “preparatory to research” – –IRB and R&D Committee review and approval required

Statement of Clinical Impact Forms

R&D Committee Review of Research The R&D Committee must evaluate the availability of adequate resources to conduct and complete the research – –Clinical hospital services must be notified if their services are required in order to conduct a research project – –Each affected service must verify resources within their respective service are adequate to conduct and complete the research project

Statement of Clinical Impact Radiology Service Nuclear Medicine Service Nursing Service Pharmacy Service Pathology and Laboratory Service Other Hospital Service

Electronic form available on Research website Items 1-7. All fields are required. Information entered on page 1 will be auto filled on pages 2 through 6. Item 8. Complete the applicable table for each VA Service that will be utilized as part of your project.

Routing Statement of Clinical Impact Forms Submit completed forms via to completed forms via to If you have any questions completing the formIf you have any questions completing the form –Contact Angela Casas in the Research office at (210) x The Research office will forward completed forms to the appropriate VA Services for signaturesThe Research office will forward completed forms to the appropriate VA Services for signatures An electronic signed copy will be provided for your recordsAn electronic signed copy will be provided for your records If project requirements change for any VA Service, a revised form must be submitted to the Research officeIf project requirements change for any VA Service, a revised form must be submitted to the Research office

Questions? Kimberly Summers, PharmD Office: (210) ext